Business people team at meeting working with charts and diagrams in office

Singapore: Draft for Comments on GN-14: Guidance on the Risk Classification of In Vitro Diagnostic Medical Devices Revision 3

The Health Sciences Authority of Singapore (HSA) is soliciting the industry’s feedback on the Draft Guidance Document: GN-14 Guidance on the Risk Classification of In Vitro Diagnostic Medical Devices Revision 3. Updates in the Draft Guidance Document includes:

  1. Inclusion of Standalone software (SaMD) definition per IMDRF;
  2. Clarifications on the classification of control materials and software; and
  3. Clarifications on risk classification rules no. 1 to 5.

Related industries that would like to submit their feedbacks on the draft guidance document may look out on the following timeline and method of submission:

Feedback period: 2 May 2023 to 30 May 2023

Feedback form: GN-14 Guidance Feedback Form 

Feedback method: Email to HSA at HSA_MD_INFO@hsa.gov.sg with subject header “Feedback on GN 14′

Draft guidance: Please refer to this link

 

If you have any queries regarding the announcement, please get in touch or click the button below.

Sign up for our regulatory roundup delivered once a month to your inbox



Scroll to Top

Stay Ahead in Southeast Asia's Medical Device Market!

Subscribe to our Newsletter

Be the first to receive essential updates on regulatory changes, market trends, and industry insights from us!

Contact Us